These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 4981706)

  • 21. Peptidoglycan biosynthesis in Escherichia coli: variations in the metabolism of alanine and D-alanyl-D-alanine.
    de Roubin MR; Mengin-Lecreulx D; van Heijenoort J
    J Gen Microbiol; 1992 Aug; 138 Pt 8():1751-7. PubMed ID: 1527514
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Inhibitory effect of D-cycloserine on beta-aminoisobutyric acid and beta-alanine metabolism. I. Increase of urinary excretion of beta-aminoisobutyric acid and beta-alanine of patients with pulmonary tuberculosis by administration of D-cycloserine, and elucidation of its mechanism].
    Yasumitsu T
    Kekkaku; 1973 May; 48(5):177-87. PubMed ID: 4732657
    [No Abstract]   [Full Text] [Related]  

  • 23. Kinetic and genetic analyses of D-cycloserine inhibition and resistance in Escherichia coli.
    Curtiss R; Charamella LJ; Berg CM; Harris PE
    J Bacteriol; 1965 Nov; 90(5):1238-50. PubMed ID: 5321479
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Regulation of Bacillus subtilis macrofiber twist development by D-cycloserine.
    Mendelson NH
    J Bacteriol; 1988 May; 170(5):2336-43. PubMed ID: 3129407
    [TBL] [Abstract][Full Text] [Related]  

  • 25. ANTAGONISM OF D-CYCLOSERINE INHIBITION OF MYCOBACTERIAL GROWTH BY D-ALANINE.
    ZYGMUNT WA
    J Bacteriol; 1963 Jun; 85(6):1217-20. PubMed ID: 14047211
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Inhibitory effect of D-cycloserine on -aminoisobutyric acid and -alanine metabolism. II. Inhibition of -aminoisobutyrate: pyruvate and -alanine: -ketoglutarate aminotransferases by -aminoxyalanine and its conjugate with -keto acids which are metabolites of D-cycloserine].
    Yasumitsu T
    Kekkaku; 1973 Jun; 48(6):227-33. PubMed ID: 4732085
    [No Abstract]   [Full Text] [Related]  

  • 27. [Evaluation of cycloserine in the treatment of infections caused by nontuberculous mycobacteria viewed from in vitro experiments].
    Tsukamura M
    Kekkaku; 1989 May; 64(5):345-9. PubMed ID: 2507817
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Mycobacterium tuberculosis survival and biofilm formation studies: effect of D-amino acids, D-cycloserine and its components.
    Kumar R; Singh N; Chauhan A; Kumar M; Bhatta RS; Singh SK
    J Antibiot (Tokyo); 2022 Aug; 75(8):472-479. PubMed ID: 35650279
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Studies on media for testing resitance to cycloserine. 4. Various lots of cycloserine and the minimal inhibitory concentration to Mycobacterium tuberculosis].
    Tamura M; Takano S
    Iryo; 1967 May; 21(5):550-2. PubMed ID: 4965697
    [No Abstract]   [Full Text] [Related]  

  • 30. In vitro effect of cycloserine on mycobacterial ultrastructure.
    Imaeda T; Kanetsuna F; Rieber M
    Tubercle; 1968 Dec; 49(4):385-96. PubMed ID: 5716378
    [No Abstract]   [Full Text] [Related]  

  • 31. A side reaction of alanine racemase: transamination of cycloserine.
    Fenn TD; Stamper GF; Morollo AA; Ringe D
    Biochemistry; 2003 May; 42(19):5775-83. PubMed ID: 12741835
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Phenotypic variability of the sensitivity to cycloserine of Klebsiella aerogenes NCTC 418, growing in chemostat culture.
    Sterkenburg A; Wouters JT
    J Gen Microbiol; 1981 May; 124(1):29-34. PubMed ID: 7033466
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Studies on the susceptibility of secondary anti-tuberculosis drugs (with special reference to the resistance-stabilities of cycloserine and ethionamide-resistant bacilli)].
    Hayashi S
    Kumamoto Igakkai Zasshi; 1970 Feb; 44(2):135-43. PubMed ID: 4986047
    [No Abstract]   [Full Text] [Related]  

  • 34. Effect of cycloserine stereoisomers and theophylline on the release of tritium from 2-tritio-L-alanine.
    Fuller RW; Snoddy HD; Molloy BB
    Res Commun Chem Pathol Pharmacol; 1976 Jul; 14(3):591-4. PubMed ID: 959661
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Inhibition of metabolism of beta-alanine and D-beta-aminoisobutyric acid by D-cycloserine.
    Yasumitsu T; Takao T; Kakimoto Y
    Biochem Pharmacol; 1976 Feb; 25(3):253-8. PubMed ID: 1267822
    [No Abstract]   [Full Text] [Related]  

  • 36. A genetic study on the cycloserine-resistance of Mycobacterium tuberculosis var. hominis.
    TSUKAMURA M; NODA Y; HAYASHI M; YAMAMOTO M
    Jpn J Microbiol; 1959 Jan; 3():1-8. PubMed ID: 13839676
    [No Abstract]   [Full Text] [Related]  

  • 37. [Influence of pH of media on the minimal inhibitory concentration of cycloserine to Mycobacterium tuberculosis].
    Tamura M; Takano S
    Kekkaku; 1965 Jun; 40(6):213-8. PubMed ID: 4955433
    [No Abstract]   [Full Text] [Related]  

  • 38. [On the effect of cycloserine and kanamycin on Mycobacterium tuberculosis (bacteriological and electron microscopic study)].
    Chertkova EI
    Probl Tuberk; 1965; 43(9):57-62. PubMed ID: 4958492
    [No Abstract]   [Full Text] [Related]  

  • 39. [Suitable pH region for resistance test of cycloserine and for the growth of Mycobacterium tuberculosis].
    Tamura M; Takano S
    Kekkaku; 1966 Nov; 41(11):517-23. PubMed ID: 4962768
    [No Abstract]   [Full Text] [Related]  

  • 40. Characterization of Chlamydia MurC-Ddl, a fusion protein exhibiting D-alanyl-D-alanine ligase activity involved in peptidoglycan synthesis and D-cycloserine sensitivity.
    McCoy AJ; Maurelli AT
    Mol Microbiol; 2005 Jul; 57(1):41-52. PubMed ID: 15948948
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.